|Mr. Peter Crock M.B.A., MBA||Chief Exec. Officer||226.19k||N/A||N/A|
|Mr. Shane Duncan||Chief Operating Officer||207.6k||N/A||N/A|
|Mr. Geoff Aldred||Chief Projects & Information Officer||158.6k||N/A||N/A|
|Ms. Geraldine T. Farrell B.Sc., FCIS, L.L.B., L.L.M.||Chief Compliance Officer & Company Sec.||155.7k||N/A||1970|
|Ms. Deborah Ambrosini||Chief Financial Officer||N/A||N/A||1974|
|Mr. Clive Fanning||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Steven Notaro||Head of Legal||N/A||N/A||N/A|
Cann Group Limited operates in the medical cannabis industry in Australia. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Bundoora, Australia.
Cann Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.